Agilent Technologies is a global leader in life sciences, diagnostics and applied chemical providing trusted answers to customers’ most challenging questions. Agilent’s expanding Cell Analysis portfolio provides solutions and support spanning many research areas. Agilent offers cell analysis solutions that detect discrete changes in cellular bioenergetics in real-time. Real-time cell measurements provide a clear window into the critical functions driving differentiation, cell signalling, proliferation, activation, toxicity and biosynthesis. Move beyond analyzing what your cells are to reveal a clearer picture of what they do.
Capacity Bio is a private biotech company developing a first-in-class mitophagy therapeutic platform and mitochondria analytical toolkit. The team has discovered the first druggable receptor that orchestrates mitophagy, or mitochondrial turnover resulting in improved mitochondrial quality. Capacity closed a $35M financing led by RA Capital, Insight Partners and Remiges Ventures, that funds the lead program through Phase 1.
Human Metabolome Technologies
Human Metabolome Technologies (HMT) is an international metabolomics company using our patented capillary electrophoresis (CE-MS) and LC-MS platforms for over 20 years.
HMT enables clients to discovery critical metabolic pathways through the profiling of over 2,500 polar metabolites using high performance CE-MS and LC-MS solutions for over 1,500 lipophilic metabolites using ultra sensitive FT-MS detection.
We provide both untargeted and quantitative solutions and C13/N15 labeled isotopomer measurements.
HMT is a collaborative partner working to help design metabolic pathways that support a wide range of applications.